Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Hugo De Bruyn; Maarten Gilbert; Liesbet Matthijs; Martens Filip; Veronique Christiaens; Luc Marks

doi:10.11607/prd.3284

Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Hugo De Bruyn, Maarten Gilbert^*, Liesbet Matthijs, Martens Filip, Veronique Christiaens, Luc Marks

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Abstract

This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.

Original language	English
Pages (from-to)	361-369
Number of pages	9
Journal	International journal of periodontics & restorative dentistry
Volume	39
Issue number	3
DOIs	https://doi.org/10.11607/prd.3284
Publication status	Published - May-2019
Externally published	Yes

Keywords

DENTAL IMPLANTS
DIABETES-MELLITUS
SYSTEMIC FACTORS
SURVIVAL
PREVALENCE
IMPACT

Access to Document

10.11607/prd.3284

Handle.net

Persistent link

Embargoed Document

Clinical Guidelines for Implant Treatment in Patients with Down Syndrome
Final publisher's version, 574 KB
Request copy

Cite this

@article{9beedc0544484eddb53b76ae849bfe15,

title = "Clinical Guidelines for Implant Treatment in Patients with Down Syndrome",

abstract = "This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.",

keywords = "DENTAL IMPLANTS, DIABETES-MELLITUS, SYSTEMIC FACTORS, SURVIVAL, PREVALENCE, IMPACT",

author = "{De Bruyn}, Hugo and Maarten Gilbert and Liesbet Matthijs and Martens Filip and Veronique Christiaens and Luc Marks",

year = "2019",

month = may,

doi = "10.11607/prd.3284",

language = "English",

volume = "39",

pages = "361--369",

journal = "International journal of periodontics & restorative dentistry",

issn = "0198-7569",

publisher = "Quintessence Publishing Co, Inc.",

number = "3",

}

TY - JOUR

T1 - Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

AU - De Bruyn, Hugo

AU - Gilbert, Maarten

AU - Matthijs, Liesbet

AU - Filip, Martens

AU - Christiaens, Veronique

AU - Marks, Luc

PY - 2019/5

Y1 - 2019/5

N2 - This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.

AB - This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.

KW - DENTAL IMPLANTS

KW - DIABETES-MELLITUS

KW - SYSTEMIC FACTORS

KW - SURVIVAL

KW - PREVALENCE

KW - IMPACT

U2 - 10.11607/prd.3284

DO - 10.11607/prd.3284

M3 - Article

SN - 0198-7569

VL - 39

SP - 361

EP - 369

JO - International journal of periodontics & restorative dentistry

JF - International journal of periodontics & restorative dentistry

IS - 3

ER -

Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Abstract

Keywords

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this